Get the Stockscreener App
1.07
4.46%
-0.05
After Hours:
1.05
-0.02
-1.87%
Rockwell Medical Inc stock is traded at $1.07, with a volume of 134.27K.
It is down -4.46% in the last 24 hours and up +28.93% over the past month.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
See More
Previous Close:
$1.12
Open:
$1.13
24h Volume:
134.27K
Relative Volume:
0.47
Market Cap:
$36.57M
Revenue:
$98.92M
Net Income/Loss:
$-1.24M
P/E Ratio:
-17.83
EPS:
-0.06
Net Cash Flow:
$2.64M
1W Performance:
-2.73%
1M Performance:
+28.93%
6M Performance:
-51.36%
1Y Performance:
-42.16%
1-Day Range:
$1.0499
$1.15
1-Week Range:
$1.0499
$1.18
52-Week Range:
$0.7801
$5.15
Rockwell Medical Inc Stock (RMTI) Company Profile
Name
Rockwell Medical Inc
Sector
Phone
(800) 449-3353
Address
30142 WIXOM ROAD, WIXOM, NJ
Compare RMTI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RMTI
Rockwell Medical Inc
|
1.07 | 38.37M | 98.92M | -1.24M | 2.64M | -0.06 |
|
ZTS
Zoetis Inc
|
152.12 | 68.04B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.48 | 46.30B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.88 | 44.25B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.54 | 18.73B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
304.50 | 13.82B | 2.99B | 1.21B | 1.13B | 25.06 |
Rockwell Medical Inc Stock (RMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Jun-24-19 | Initiated | Piper Jaffray | Overweight |
| May-13-19 | Initiated | H.C. Wainwright | Buy |
| Nov-08-16 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Mar-01-16 | Downgrade | Stifel | Buy → Hold |
| Aug-13-15 | Initiated | Morgan Stanley | Underweight |
| Jan-27-15 | Reiterated | Oppenheimer | Outperform |
| Jan-07-15 | Initiated | Oppenheimer | Outperform |
| Aug-14-14 | Initiated | FBR Capital | Underperform |
| Dec-19-13 | Initiated | Chardan Capital Markets | Buy |
| Nov-06-13 | Reiterated | Summer Street Research | Buy |
| Sep-05-13 | Reiterated | Summer Street Research | Buy |
| Aug-02-13 | Reiterated | Summer Street Research | Buy |
| Apr-11-12 | Initiated | Summer Street Research | Buy |
| Mar-12-12 | Initiated | Stifel Nicolaus | Buy |
| Jan-03-12 | Initiated | Canaccord Genuity | Buy |
| Dec-10-09 | Initiated | JMP Securities | Mkt Outperform |
| Oct-12-09 | Initiated | Wedbush Morgan | Outperform |
View All
Rockwell Medical Inc Stock (RMTI) Latest News
Rockwell Medical, Innovative Renal Care Partner on Hemodialysis Product Continuity - Medical Product Outsourcing
Will Rockwell Medical Inc. stock benefit from interest rate changesPhenomenal wealth increase - jammulinksnews.com
What drives Rockwell Medical Inc. stock priceMarket-leading capital gains - Autocar Professional
Rockwell Medical Inc. Stock Analysis and ForecastRapid return acceleration - Autocar Professional
Is Rockwell Medical Inc. a good long term investmentAccelerated earnings growth - Autocar Professional
Hemodialysis Therapy Market is projected to grow to USD 19.81 - openPR.com
What analysts say about Rockwell Medical Inc. stockUnstoppable profit momentum - jammulinksnews.com
Why Rockwell Medical Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser
Rockwell Medical to Release Second Quarter 2025 Results on Thursday, August 14, 2025 - Business Wire
META_TITLE_SECTORS - Yahoo Finance
What makes Rockwell Medical Inc. stock price move sharplyFree Stock Movement Tracking - Newser
How Rockwell Medical Inc. stock performs during market volatilityFree Consultation - Newser
RMTI’s Stock Market Adventure: -38.25% YTD Growth Amidst Volatility - investchronicle.com
Healthcare Stocks to Watch: Evaxion Biotech, CVRx, and Rockwell Medical Receive Bullish Sentiments - AInvest
Rockwell Medical, Inc. (NASDAQ:RMTI) Held Back By Insufficient Growth Even After Shares Climb 25% - simplywall.st
Rockwell Medical Soars 13.45% on Strategic Partnership - AInvest
Rockwell Medical's Strategic Initiatives and Market Positioning Support Buy Rating with $3 Price Target - AInvest
Rockwell Medical signs multi-year supply agreement with Innovative Renal Care - Investing.com Nigeria
Rockwell Medical and Innovative Renal Care Announce Three-Year Partnership Agreement to Ensure Supply Chain Continuity of Quality Hemodialysis Products - MarketScreener
Rockwell Medical signs multi-year supply agreement with Innovative Renal Care By Investing.com - Investing.com South Africa
Rockwell Medical, Inc.(NasdaqCM: RMTI) added to Russell Microcap Value Index - MarketScreener
Iron Deficiency Anemia Market Trends: Rising Demand for IV Iron - openPR.com
Intravenous Iron Drugs Market to Reach USD 6.63 Bn by 2032 - newstrail.com
Rockwell Medical (NASDAQ:RMTI) Raised to Hold at Wall Street Zen - Defense World
Millennium Management LLC Cuts Position in Rockwell Medical, Inc. (NASDAQ:RMTI) - Defense World
RMTIRockwell Medical Announces First Quarter 2025 Results - Revista ADVFN
Dialysis Equipment Market to Reach $191.24 Bn by 2032 - newstrail.com
Key Market Driver in intravenous iron drugs Industry 2025: RisinNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Iron Deficiency Anemia Market Accelerates with Health Programs - openPR.com
Rockwell Medical (NASDAQ:RMTI) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Dialysate Market Insights: Growing at 6.04% CAGR to USD 9.8 Billion by 2031 - openPR.com
HC Wainwright Issues Pessimistic Estimate for RMTI Earnings - Defense World
Rockwell Medical Inc Stock (RMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rockwell Medical Inc Stock (RMTI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Neri Jesse | SVP and CFO |
Jul 01 '25 |
Sale |
0.82 |
886 |
727 |
126,614 |
| Strobeck Mark | President and CEO |
Jul 01 '25 |
Sale |
0.82 |
6,926 |
5,679 |
337,752 |
2.82%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):